Vioxx rofecoxib cancer data

In the 3-year, double-blind, placebo-controlled APPROVe trial in 2,600 patients, 15 patients per 1,000 given 25 mg of Vioxx had a confirmed cardiovascular event, compared to 7.5 patients per 1,000 giv...